J&J $1.7B V-Wave Buy Strengthens Cardiovascular Portfolio

0
121

As Johnson & Johnson acquires V-Wave Ltd., the companies advance their leadership in cardiovascular care with a new technology to expand treatment options for patients suffering from heart failure.